StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$46.55+0.42 (+0.91%)

Close on Oct 19, 2026Market cap $10.10BP/E 24.0Yield 0.54%

Qiagen pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Qiagen's pe ratio was 25.9× on Nov 11, 2026, against 135.8× a year earlier. Over the last 5 years it ranged from 17.8× to 145.1×, with a median of 26.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202625.9×−102.0
2025Dec 31, 2025127.9×+97.9
2024Dec 31, 202430.1×+5.2
2023Dec 29, 202324.8×+1.1
2022Dec 30, 202223.8×−14.5
2021Dec 31, 202138.2×−7.8
2020Feb 28, 202046.1×+2.7
2019Dec 31, 201943.4×−169.9
2018Dec 31, 2018213.3×+117.5
2017Dec 29, 201795.8×+42.1
2016Dec 30, 201653.6×−7.0
2015Dec 31, 201560.6×−24.5
2014Dec 31, 201485.1×+38.7
2013Dec 31, 201346.4×−1.4
2012Dec 31, 201247.8×+23.5
2011Dec 30, 201124.2×−7.9
2010Dec 31, 201032.2×−21.3
2009Dec 31, 200953.4×–

More Qiagen figures

See a number that looks wrong?